Company Filing History:
Years Active: 2013
Title: Milai Yin - Innovator in Pharmaceutical Chemistry
Introduction
Milai Yin is a notable inventor based in Guangdong, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of compounds.
Latest Patents
Milai Yin holds a patent for the crystalline form I of 3,4'5-trihydroxy-stilbene-3-β-D-glucoside, commonly known as polydatin. This invention relates to a novel crystalline form of the compound and includes a method of preparation and use. The crystalline form I exhibits a stable morphology, a defined melting point, and good chemical stability. These properties are essential for the preparation of solid formulations, allowing for reduced raw material costs and improved production efficiency. The invention also enhances quality control in industrial drug production and offers better convenience in storage.
Career Highlights
Milai Yin is associated with Shenzhen Neptunus Pharmaceutical Holdings Co., Ltd., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the formulation of pharmaceutical compositions.
Collaborations
Milai has collaborated with notable colleagues, including Hui Kang and Jinhua Zhao, contributing to various projects within the pharmaceutical sector.
Conclusion
Milai Yin's innovative work in the field of pharmaceutical chemistry, particularly with his patent on crystalline forms, showcases his commitment to enhancing drug formulation and production processes. His contributions are valuable to the industry and highlight the importance of innovation in pharmaceuticals.